A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

NCT01592110 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: risperidone-SABER
OTHER: ZX003:risperidone-SABER and the DosePro System
DRUG: risperidone-SABER
DRUG: Risperidone-SABER

Sponsor

Zogenix, Inc.